Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05272826 |
| Title | Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients (BOREALIS) |
| Acronym | BOREALIS |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Canadian Myeloma Research Group |
| Indications | |
| Therapies | |
| Age Groups: | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| QEII Health Science Centre | RECRUITING | Halifax | Nova Scotia | Canada | Details | |
| London Health Sciences Centre | RECRUITING | London | Ontario | Canada | Details | |
| Princess Margaret Hospital | RECRUITING | Toronto | Ontario | Canada | Details | |
| Hôpital Maisonneuve-Rosemont | RECRUITING | Montreal | Quebec | Canada | Details | |
| McGill University Health Centre | RECRUITING | Montreal | Quebec | Canada | Details |